X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
24
PharmaCompass offers a list of Tinidazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tinidazole manufacturer or Tinidazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tinidazole manufacturer or Tinidazole supplier.
PharmaCompass also assists you with knowing the Tinidazole API Price utilized in the formulation of products. Tinidazole API Price is not always fixed or binding as the Tinidazole Price is obtained through a variety of data sources. The Tinidazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane, including repackagers and relabelers. The FDA regulates 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane supplier is an individual or a company that provides 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane active pharmaceutical ingredient (API) or 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane finished formulations upon request. The 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane suppliers may include 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane API manufacturers, exporters, distributors and traders.
click here to find a list of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane DMF (Drug Master File) is a document detailing the whole manufacturing process of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane active pharmaceutical ingredient (API) in detail. Different forms of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane DMFs exist exist since differing nations have different regulations, such as 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane DMF submitted to regulatory agencies in the US is known as a USDMF. 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane USDMF includes data on 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane Drug Master File in Japan (1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane JDMF) empowers 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane JDMF during the approval evaluation for pharmaceutical products. At the time of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane suppliers with JDMF on PharmaCompass.
A 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CEP of the European Pharmacopoeia monograph is often referred to as a 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane Certificate of Suitability (COS). The purpose of a 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane to their clients by showing that a 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CEP has been issued for it. The manufacturer submits a 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CEP (COS) as part of the market authorization procedure, and it takes on the role of a 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CEP holder for the record. Additionally, the data presented in the 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane DMF.
A 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane suppliers with CEP (COS) on PharmaCompass.
A 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane written confirmation (1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane WC) is an official document issued by a regulatory agency to a 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane manufacturer, verifying that the manufacturing facility of a 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane APIs or 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane finished pharmaceutical products to another nation, regulatory agencies frequently require a 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane WC (written confirmation) as part of the regulatory process.
click here to find a list of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane suppliers with NDC on PharmaCompass.
1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane GMP manufacturer or 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane GMP API supplier for your needs.
A 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CoA (Certificate of Analysis) is a formal document that attests to 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane's compliance with 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane specifications and serves as a tool for batch-level quality control.
1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CoA mostly includes findings from lab analyses of a specific batch. For each 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane may be tested according to a variety of international standards, such as European Pharmacopoeia (1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane EP), 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane USP).
Market Place
